| Filed On | Filing |
|---|---|
| 18 Feb 2025 |
8-K/A: Regulation FD Disclosure; Other Events
– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving complete renal response, and the first dermatomyositis patient maintaining a major TIS improvement; each of thes... |
| 14 Mar 2022 | 8-K/A: Regulation FD Disclosure |
Loading...
